Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0YM7U
|
||||
| Former ID |
DCL000627
|
||||
| Drug Name |
Rituxan Hemotalogy/oncology
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Non-hodgkin's lymphoma [ICD10:C85] | Approved | [544126] | ||
| Company |
Genentech
|
||||
| Target and Pathway | |||||
| Target(s) | B-lymphocyte antigen CD20 | Target Info | [550797] | ||
| KEGG Pathway | Hematopoietic cell lineage | ||||
| References | |||||